Cost of Illness in Patients with Duchenne Muscular Dystrophy in Portugal: The COIDUCH Study | SpringerLink
Consensus on the diagnosis, treatment and follow-up of patients with Duchenne muscular dystrophy | Neurología (English Edition)
CRISPR applications for Duchenne muscular dystrophy: From animal models to potential therapies - Chey - WIREs Mechanisms of Disease - Wiley Online Library
DMD genotypes and loss of ambulation in the CINRG Duchenne Natural History Study | Neurology
Clinical characteristics of DMD. a Muscular involvement in the DMD... | Download Scientific Diagram
Consensus on the diagnosis, treatment and follow-up of patients with Duchenne muscular dystrophy | Neurología (English Edition)
Muscle membrane integrity in Duchenne muscular dystrophy: recent advances in copolymer-based muscle membrane stabilizers | Skeletal Muscle | Full Text
PDF) Characterizing health state utilities associated with Duchenne muscular dystrophy: a systematic review
Drug Discovery of Therapies for Duchenne Muscular Dystrophy - SLAS Discovery
Deflazacort, Eteplirsen, and Golodirsen for Duchenne Muscular Dystrophy: Effectiveness and Value
Viltolarsen in Japanese Duchenne muscular dystrophy patients: A phase 1/2 study - Komaki - 2020 - Annals of Clinical and Translational Neurology - Wiley Online Library
Nutrients | Free Full-Text | Metabogenic and Nutriceutical Approaches to Address Energy Dysregulation and Skeletal Muscle Wasting in Duchenne Muscular Dystrophy | HTML
The effect of steroid treatment on weight in nonambulatory males with Duchenne muscular dystrophy - Lamb - 2018 - American Journal of Medical Genetics Part A - Wiley Online Library
A new era in the management of Duchenne muscular dystrophy - Korinthenberg - 2019 - Developmental Medicine & Child Neurology - Wiley Online Library
Consensus on the diagnosis, treatment and follow-up of patients with Duchenne muscular dystrophy | Neurología (English Edition)
Pig models for Duchenne muscular dystrophy – from disease mechanisms to validation of new diagnostic and therapeutic concepts - ScienceDirect
PDF) Reliability of the walking energy cost test and the six-minute walk test in boys with Duchenne muscular dystrophy
Rimeporide as a first- in-class NHE-1 inhibitor: Results of a phase Ib trial in young patients with Duchenne Muscular Dystrophy - ScienceDirect
Shorter Phosphorodiamidate Morpholino Splice-Switching Oligonucleotides May Increase Exon-Skipping Efficacy in DMD - ScienceDirect
PDF) Genotype characterization and delayed loss of ambulation by glucocorticoids in a large cohort of patients with Duchenne muscular dystrophy
Structure-activity relationships of 2-pyrimidinecarbohydrazides as utrophin modulators for the potential treatment of Duchenne muscular dystrophy - ScienceDirect
BMI-z scores of boys with Duchenne muscular dystrophy already begin to increase before losing ambulation: a longitudinal exploration of BMI, corticosteroids and caloric intake - Neuromuscular Disorders
Pig models for Duchenne muscular dystrophy – from disease mechanisms to validation of new diagnostic and therapeutic concepts - Neuromuscular Disorders
Briefing Document
CRISPR technologies for the treatment of Duchenne muscular dystrophy: Molecular Therapy
